(Total Views: 504)
Posted On: 04/23/2020 9:45:04 AM
Post# of 1460
AVXL press release: they are using AI to look at biomarkers to see who is a suitable candidate for the drug.
http://pdf.reuters.com/htmlnews/htmlnews.asp?...nGNX7M9QqF
http://pdf.reuters.com/htmlnews/htmlnews.asp?...nGNX7M9QqF
Quote:
AVXLtoday announced the publication in the peer-reviewed journal, Alzheimer's & Dementia: Translational Research & Clinical Interventions, entitled, “A precision medicine framework using Artificial Intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer’s disease therapy: Analysis of the Blarcamesine (ANAVEX2-73) Phase 2a clinical study.“
(2)
(0)
